- Buteyko is a training program built on one idea: that most people chronically over-breathe, and that breathing less raises carbon dioxide and improves health.
- The evidence base is almost entirely asthma. A 2024 review commissioned by Australia’s national health research council found low-certainty evidence that it may reduce asthma symptoms, and very uncertain evidence for everything else.
- For the uses it is most often sold for outside asthma — sleep, anxiety, dysfunctional breathing — that review found no eligible studies at all.
- The control pause, the breath-hold measurement at the center of the method, has no validation study behind it that we could find.
- If you have asthma, the one rule that matters on this page is that you do not change your medication because of a breathing exercise.
What the Buteyko Method Is
Konstantin Buteyko was a Soviet physician who proposed in the 1950s that a large share of chronic illness comes from breathing too much — that habitual over-breathing washes carbon dioxide out of the blood, and that a great many symptoms follow from the deficit. The method he built is the corrective: breathe less, breathe through the nose, and train tolerance for the discomfort that comes with it.
That makes it different in kind from most of what is on this site. Box breathing or 4-7-8 are patterns you run for two minutes. Buteyko is a program — a set of exercises, a measurement you track, a set of habits about how you breathe the rest of the day, and usually a teacher. It is closer to physiotherapy than to a breathing exercise.
It is also the most contested technique covered here, and the gap between what it is marketed for and what has been tested is the widest. Both of those are worth taking seriously rather than dismissing, because the asthma evidence is real — it is just narrower than the claims built on it.
The Core Exercises
- Measure the control pause. Sit still for a few minutes. After a normal exhale, pinch your nose and time how long until you feel the first definite urge to breathe — not how long you can hold. Release and breathe normally through the nose. If your first breath afterward is a gasp, you pushed past the measurement and the number is meaningless.
- Breathe through your nose. All the time. This is the habit change the method rests on, and the part with the clearest rationale. Awake, asleep, walking, exercising where you can.
- Practice reduced breathing. Sitting upright, relax the chest and belly and let each breath become slightly smaller than it wants to be, until you feel a mild but tolerable air hunger. Hold that for three to five minutes. Mild is the operative word — this is not breath holding, and it should never become distressing.
- Recover, then repeat. A minute of normal nasal breathing between sets. Three or four sets is a session.
- Re-measure the control pause afterward. A rising number over weeks is what practitioners track. What that number means is a separate question, taken up below.
Buteyko is normally taught in person over several weeks, and the trials that found benefits all used a taught program rather than a set of written instructions. That is worth knowing before judging it on a solo attempt from a web page — including this one.
What the Evidence Actually Shows
In 2024 Australia’s National Health and Medical Research Council commissioned Cochrane Australia to evaluate the Buteyko method as part of a review of natural therapies. It found 11 eligible trials across every condition the method is used for. That review is the single most useful thing written about Buteyko’s evidence base, and most of what follows comes from it.
| Claim | Verdict | What the Research Actually Says |
|---|---|---|
| It reduces asthma symptoms | Qualified | The 2024 NHMRC-commissioned review found low-certainty evidence that Buteyko may reduce asthma symptoms in adults and children — the only outcome across every condition assessed that reached even low certainty.1 Cochrane's broader review is less positive: its meta-analysis of Asthma Control Questionnaire scores was inconclusive at both three and six months, and it concluded breathing exercises probably do not improve asthma symptoms on that measure.2 A 2026 randomized trial of 90 patients found a large improvement in asthma control after six weeks (ACT 14.4 to 20.2, d = 1.34), though the control arm received routine care only, so attention and expectation are not separated out.3 |
| It improves quality of life and breathing symptoms in asthma | Qualified | Cochrane's review of breathing exercises for asthma — 22 studies, 2,880 adults, of which Buteyko is one technique among several — found probable improvement in quality of life at three months, and improvement in hyperventilation symptoms from four to six months. Certainty across outcomes ranged from moderate to very low, and only mild-to-moderate asthma was studied.2 |
| It improves objective lung function | Qualified | Cochrane's two lung function measures disagree. Absolute FEV1 at three months was inconclusive at very low certainty; FEV1 as a percentage of predicted improved by 6.88 points (95% CI 5.03 to 8.73) favouring breathing exercises.2 That is a real result on one measure and nothing on the other, in a review covering breathing exercises generally rather than Buteyko alone — the Buteyko-specific review rated lung function evidence very uncertain.1 |
| It helps with sleep, snoring, anxiety or dysfunctional breathing | Not Shown | The 2024 review looked for trials of Buteyko in sleep disorders, dysfunctional breathing and anxiety disorders — three of the conditions practitioners most commonly treat with it — and found no eligible studies at all.1 Not weak evidence. None. |
| The control pause measures your health | Not Shown | We could find no study validating the control pause against any clinical outcome, and none establishing that a longer pause predicts better health. It is a repeatable measurement of breath-hold tolerance, which is not the same as a measure of anything else. |
Two things are worth pulling out of that table. The first is that the asthma finding is genuine but contested — the Buteyko-specific review says it may reduce symptoms at low certainty, while Cochrane’s broader meta-analysis of symptom questionnaires came out inconclusive. Those are not the same answer, and a page that reports only the friendlier one is not describing the evidence. The second is the size of the gap. Buteyko is taught for sleep apnea, snoring, anxiety, panic, athletic performance and long COVID. For three of those, an independent review looking specifically for trials found zero.
The Theory, and Where It Overreaches
The physiology Buteyko rests on is partly sound. Carbon dioxide is not merely waste — it drives the urge to breathe, and it shifts the oxygen-hemoglobin dissociation curve so that blood releases oxygen to tissue more readily when CO₂ is high. That is the Bohr effect, and it is textbook. Hyperventilation genuinely does lower arterial CO₂ and genuinely does produce symptoms, which is why hyperventilation syndrome is a recognized clinical entity.
From “hyperventilation causes symptoms” the method moves to “most people chronically hyperventilate” and then to “correcting it treats a wide range of disease.” Neither of those steps has been demonstrated. Chronic low-grade over-breathing in the general population is asserted far more often than it is measured, and the leap from a real acute phenomenon to a general theory of chronic illness is the part that has never been tested — which is exactly what the 2024 review found when it went looking.1
There is one finding that cuts in Buteyko’s favor, and it is worth stating: Cochrane’s asthma review found that breathing exercises improved hyperventilation symptoms from four to six months.2 That is a partial vindication of the premise — some people with asthma do have a breathing pattern component, and addressing it helps them feel better. It is a long way from the general theory, but it is not nothing.
The Control Pause Is Not a Health Measure
Buteyko practitioners treat the control pause as a vital sign: under 10 seconds is serious illness, 20 is typical of the unwell, 40 is health, 60 is the goal. Those thresholds appear in teaching materials, apps and articles, stated as fact.
We could not find a study validating them. Not one establishing that a control pause of 40 corresponds to better health than 25, nor one showing that raising your number changes any clinical outcome. What the measurement plausibly reflects is breath-hold tolerance — a mix of CO₂ sensitivity, lung volume, practice, and how comfortable you are with the sensation of wanting to breathe. Trained freedivers score high on it. That tells you something about them, but not that the number is a health metric.
It is still useful as a progress marker in the narrow sense — if you practice, it goes up, and watching it go up keeps people practicing. That is a legitimate function. It is not a diagnostic.
When Something Else Is the Better Choice
- You want a breathing practice for anxiety or sleep. Buteyko has no trials for either. Breathwork in general does have them, with small-to-medium reductions in stress and anxiety across 12 randomized trials.4 Start with a longer exhale rather than a smaller breath.
- You want the measured autonomic effect. Breathing at six a minute has the most direct support for raising heart rate variability, and needs no training program. The coherent breathing pacer runs it.
- You have asthma and want to try breathing retraining. This is the one place Buteyko has a real claim — but the trials used taught programs, and the sensible route is through a respiratory physiotherapist rather than a web page.
- Air hunger frightens you. Reduced breathing deliberately produces the sensation of not getting enough air. For some people that is the trigger they are trying to get away from.
What Buteyko has that the paced patterns do not is the nasal breathing habit. Whatever the fate of the wider theory, shifting from habitual mouth breathing to nasal breathing is a change with a clear rationale and no real downside, and it is the part of the method most worth keeping.
Safety, and the Medication Rule
Reduced reliever use is one of the outcomes reported in Buteyko trials, and it is the finding most likely to be misread. In those trials medication was adjusted under medical supervision, as a result of improvement — not as a technique for producing it. Reducing a preventer inhaler because your breathing feels better is how a manageable condition becomes an emergency, and feeling better is not evidence that airway inflammation has changed.
Nothing on this page is a reason to alter a prescription. If you want to reduce medication, that conversation belongs with the clinician who prescribed it, and the evidence above is not strong enough to open it on its own.
Reduced breathing and breath holds are not neutral. Talk to a doctor first if you are pregnant, or if you have uncontrolled asthma, a cardiovascular condition, uncontrolled blood pressure, epilepsy or a seizure history, diabetes, kidney disease, panic disorder, or any condition affected by changes in blood gases. Never practice breath holds in or near water, and not while driving.
Stop if air hunger becomes distress rather than mild discomfort, or if you feel dizzy, get chest tightness, or find your breathing harder rather than easier afterward. Reduced breathing done too aggressively can provoke the symptoms it is meant to settle.
If You Want to Try It Anyway
None of the above says do not. It says know what you are buying. The trials that found benefit ran taught programs over four to six weeks with weekly supervision,3 so a fair trial of the method is that, not ten minutes from a video. If you have asthma, going through a respiratory physiotherapist gets you the same training with someone watching your medication.
The cheapest useful piece to adopt on your own is the nasal breathing habit — during the day first, then during easy exercise. It requires no measurement and makes no claims that need defending. If after a few weeks nothing has changed, that is worth knowing too, and it is a better test than an increasing control pause.
Common Questions
Does Buteyko work for asthma?
There is low-certainty evidence that it may reduce asthma symptoms — the only outcome in the 2024 independent review to reach even that bar. What it does not appear to do is change objective lung function, so it is an adjunct to treatment rather than a treatment. Anyone with asthma should approach it through a clinician, not instead of one.
What is a good control pause?
The published thresholds — 40 seconds for health, 60 as a goal — are not backed by any validation study we could find. The measurement reliably reflects your tolerance for breath holding, which rises with practice. Treat a rising number as evidence that you have been practicing, not as evidence that you are getting healthier.
Can Buteyko replace my inhaler?
No. Reduced medication use appears in some trials, but it was adjusted by doctors following improvement, not used as a method of producing it. Feeling better is not the same as airway inflammation improving, and that gap is where the danger is. Any change to a prescription belongs with the person who wrote it.
Do I really breathe too much?
Probably not, and it has not been shown that most people do. Acute hyperventilation is real and produces real symptoms. The claim that low-grade chronic over-breathing is widespread and causes chronic disease is a much bigger one, and it is asserted far more often than it is measured.
Is mouth taping at night part of this?
It is often taught alongside Buteyko, and it is not covered by the evidence discussed here. It also carries real risk for anyone with untreated sleep apnea, nasal obstruction, or who has been drinking, and it is not something to try on the basis of a breathing method’s popularity.
Why does this site rate it Thin Evidence when it is so widely taught?
Because our badge describes what has been demonstrated, not how many people teach it. Eleven trials across every condition, all small, all at high risk of bias, with one outcome reaching low certainty and nothing at all for most of the uses it is sold for. That is a fair description of preliminary evidence, and being widely taught is not evidence.
The Short Answer
Buteyko has one plausible use — reducing symptoms in mild to moderate asthma, at low certainty, as an adjunct to proper treatment — and a great many claimed uses with no trials behind them at all. The physiology it starts from is real; the general theory built on it has not been tested and probably cannot carry the weight put on it. The control pause is a practice tracker, not a vital sign. The nasal breathing habit is the part worth keeping regardless. And if you have asthma, nothing here is a reason to touch your medication.
Buteyko is a training program rather than a timed exercise, so there is no timer for it. If you want slow breathing with better evidence behind it, start here.
- Cochrane Australia (2024). Systematic review of evidence on the clinical effectiveness of Buteyko. Commissioned by the National Health and Medical Research Council, Australian Government Department of Health, November 2024. health.gov.au — 11 eligible trials across all conditions assessed.
- Santino, T. A., Chaves, G. S. S., Freitas, D. A., Fregonezi, G. A. F., and Mendonça, K. M. P. P. (2020). Breathing exercises for adults with asthma. Cochrane Database of Systematic Reviews, Issue 3, CD001277. doi:10.1002/14651858.CD001277.pub4
- Neşe, A., and İpekçioğlu, F. (2026). The effect of the Buteyko breathing technique on fatigue, exercise capacity, and asthma control in patients with asthma: a randomized controlled trial. Irish Journal of Medical Science, 195, 1811–1823. doi:10.1007/s11845-026-04382-3
- Fincham, G. W., Strauss, C., Montero-Marin, J., and Cavanagh, K. (2023). Effect of breathwork on stress and mental health: a meta-analysis of randomised-controlled trials. Scientific Reports, 13, 432. doi:10.1038/s41598-022-27247-y
Jay Newmark is a health writer with a background in kinesiology and seven years covering sleep, stress, and performance science for digital health and fitness publications. He writes about breathwork from a science-first perspective.